v3.25.4
Schedule I Condensed Balance Sheets (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Current assets:        
Cash and cash equivalents $ 24,365 $ 25,312    
Total current assets 90,582 85,779    
Other assets 23,013 19,590    
Total assets 309,581 298,278 $ 273,720  
Current liabilities:        
Accounts payable and accrued liabilities 38,032 34,337    
Total current liabilities 114,897 103,769    
Long-term debt, less current maturities 72,320 72,359    
Other liabilities 18,245 15,939    
Total liabilities 207,883 195,687    
Commitments and contingencies (Note 4)    
Shareholders’ equity:        
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding 0 0    
Common stock, $0.01 par value - 3,000 shares authorized; 906 and 915 issued and outstanding 9 9    
Additional paid-in capital 559 0    
Retained earnings 95,603 96,036    
Accumulated other comprehensive loss (2,061) (3,387)    
Total liabilities and shareholders’ equity 309,581 298,278    
Parent Company [Member]        
Current assets:        
Cash and cash equivalents 303 234 $ 776 $ 266
Other current assets 1,533 411    
Total current assets 1,836 645    
Equity in net assets of subsidiaries 206,415 179,888    
Other assets 673 920    
Total assets 209,603 187,515    
Current liabilities:        
Accounts payable and accrued liabilities 2,812 1,501    
Intercompany payable, net 10,236 679    
Short-term notes payable to subsidiaries 2,500 2,000    
Short-term borrowings and current maturities of long-term debt 5,887 4,348    
Total current liabilities 21,438 8,544    
Long-term debt, less current maturities 71,794 71,831    
Long-term notes payable to subsidiaries 21,700 14,400    
Other liabilities 585 77    
Total liabilities 115,493 94,857    
Shareholders’ equity:        
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding 0 0    
Common stock, $0.01 par value - 3,000 shares authorized; 906 and 915 issued and outstanding 9 9    
Additional paid-in capital 559 0    
Retained earnings 95,603 96,036    
Accumulated other comprehensive loss (2,061) (3,387)    
Total UnitedHealth Group shareholders' equity 94,110 92,658    
Total liabilities and shareholders’ equity 209,603 187,515    
Parent Company [Member] | Subsidiaries [Member]        
Current assets:        
Long-term notes receivable from subsidiaries 679 6,062    
Current liabilities:        
Short-term notes payable to subsidiaries 2,503 2,016    
Long-term notes payable to subsidiaries $ 21,676 $ 14,405